U.S. Patent Office invalidates American Well patent, follows
Teladoc’s victory in federal court
LEWISVILLE, Texas--(BUSINESS WIRE)--
Teladoc, Inc. (NYSE: TDOC), the nation’s first and largest telehealth
provider, today announced the U.S. Patent and Trademark Office (USPTO)
has invalidated the major elements of a telemedicine patent held by
American Well Corporation on the basis that they were not patentable
because American Well did not invent them. The USPTO took this action at
the request of Teladoc. At issue before the USPTO were the same elements
of the American Well patent that a Massachusetts federal court declared
invalid earlier this year on a separate basis.
“For more than a year, we have challenged American Well’s patent
portfolio as invalid, advocating on behalf of the industry so innovation
and increased access to health care can continue to thrive,” said Adam
Vandervoort, Teladoc chief legal officer. “Teladoc is extremely pleased
by the decisions of both the U.S. Patent and Trademark Office and the
Massachusetts federal court.”
About Teladoc
Teladoc, Inc. (NYSE:TDOC) is the nation’s leading provider of telehealth
services and a pioneering force in bringing the virtual care visit into
the mainstream of today’s health care ecosystem. Serving some 6,000
clients — including health plans, health systems, employers and other
organizations — more than 15 million members can use phone, mobile
devices and secure online video to connect within minutes to Teladoc’s
network of more than 3,100 board-certified, state-licensed physicians
and behavioral health specialists, 24/7. With national coverage, a
robust, scalable platform and a Lewisville, Texas-based member services
center staffed by 400 employees, Teladoc offers the industry’s most
comprehensive and complete telehealth solution including primary care,
behavioral health care, dermatology, tobacco cessation and more. For
additional information, visit www.teladoc.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160825006029/en/
Source: Teladoc, Inc.